UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060001
Receipt number R000068623
Scientific Title A Prospective Observational Study on the Association Between Oral Hypofunction and Overactive Bladder in Dental Examinations
Date of disclosure of the study information 2025/12/31
Last modified on 2025/12/07 01:04:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on the Relationship Between Oral Hypofunction and Overactive Bladder

Acronym

Oral Function and OAB Study

Scientific Title

A Prospective Observational Study on the Association Between Oral Hypofunction and Overactive Bladder in Dental Examinations

Scientific Title:Acronym

OFD OAB Study

Region

Japan


Condition

Condition

Oral Dysfunction Syndrome and Overactive Bladder

Classification by specialty

Urology Oral surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to clarify the association between objectively assessed oral hypofunction during dental examinations and overactive bladder (OAB). Recent studies have reported that impaired oral function may influence systemic inflammation and autonomic nervous activity, suggesting a potential role in the development or exacerbation of OAB. In this study, we will evaluate oral function tests and urinary symptom questionnaires administered to patients visiting dental and urology clinics, and investigate the relationship between these factors.

Basic objectives2

Others

Basic objectives -Others

Investigation of the association between the two diseases

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The association between the presence of overactive bladder and oral hypofunction

Key secondary outcomes

The association between OABSS scores and the presence of oral hypofunction
The association between the presence of OAB and individual components of oral hypofunction
The association between OABSS sub-scores and the presence of oral hypofunction
The association between the presence of OAB and salivary metabolites


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

YES

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Maneuver

Interventions/Control_1

At the initial visit, participants will undergo a one-time clinical assessment for oral hypofunction and complete a urinary symptom questionnaire.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Adults aged 40 years or older who attend the Department of Oral and Maxillofacial Surgery or the Department of Urology at Yamagata University Hospital.
Individuals who receive a written explanation of the purpose and procedures of the study and provide voluntary written informed consent.
Individuals who are able to undergo oral function assessments and evaluations using urinary symptom scores.
Individuals who are able to provide a saliva sample (approximately 2 or 3 mL collected by the passive drool method).

Key exclusion criteria

Individuals who have difficulty completing the questionnaires due to cognitive impairment or other reasons.
Individuals with severe systemic illness (such as acute inflammation or advanced cancer) for whom participation in the study is deemed inappropriate by the attending physician.
Individuals who have already received pharmacological or surgical treatment for benign prostatic hyperplasia (BPH) or overactive bladder (OAB).

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Suguru
Middle name
Last name Ito

Organization

Yamagata University Faculty of Medicine

Division name

Department of Urology

Zip code

9909585

Address

2-2-2 Iida-Nishi, Yamagata-shi, Yamagata

TEL

0236285368

Email

sugu1219@yahoo.co.jp


Public contact

Name of contact person

1st name Suguru
Middle name
Last name Ito

Organization

Yamagata University Faculty of Medicine

Division name

Department of Urology

Zip code

9909585

Address

2-2-2 Iida-Nishi, Yamagata-shi, Yamagata

TEL

0236285368

Homepage URL


Email

sugu1219@yahoo.co.jp


Sponsor or person

Institute

Yamagata University

Institute

Department

Personal name

Suguru Ito


Funding Source

Organization

Yamagata University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

the Ethical Review Committee of Yamagata University Faculty of Medicine

Address

2-2-2 Iida-Nishi, Yamagata-shi, Yamagata

Tel

08016705845

Email

sugu1219@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW

Yamagata


Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 12 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 11 Month 01 Day

Date of IRB


Anticipated trial start date

2026 Year 01 Month 01 Day

Last follow-up date

2029 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 12 Month 07 Day

Last modified on

2025 Year 12 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068623